17th annual European Pharmaceutical Pricing & Reimbursement
/EINPresswire.com/ SMi is proud to present their 17th annual conference…
European Pharmaceutical Pricing & Reimbursement
31st October & 1st November 2011, Radisson Blu Hotel Basel, Basel, Switzerland
>>> New confirmed speaker: Gary Johnson, Managing Director, Inpharmation
who will be presenting on the following topic: New Realities and New Approaches in European Pricing Strategies
With only 3 weeks remaining, reserve your place today and be part of this exciting event where you will hear key industry speakers discussing the latest pricing and market access developments and challenges currently facing the pharmaceutical sector.
Attendees will be presented with pricing strategies and solutions to current issues in European pharmaceutical market access. Key industry experts will present updates on the VBP and the AMNOG, referring to real life case studies, strategies and success stories in health technology assessment mechanisms and pricing and reimbursement strategies. This year's event will act as the perfect forum for thought provoking discussions and networking with our diverse speaker line up, each offering a different industry perspective.
Key Topics Include:
EU policy challenges in access to medicines in Europe: the value of collaboration in HTA and managed entry schemes
• Assessment and Appraisal: is there a scope for European collaboration in HTA to prove clinical value to governments and payers?
• How the new challenges of "valuable innovation" can be addressed in order to meet priorities in healthcare?
• Will Managed Entry Schemes provide a refined tool to address uncertainties in patient's access?
• Can stakeholders contribute effectively to the setting of shared rules?
Andrea Rappagliosi, Vice President European Government Affairs & Head of Brussels Office, GSK
Benefits of Attending:
• Understand the facts and consequences of Germany's AMNOG
• Discuss EU policy challenges in access to medicines in Europe
• Analyse Market access strategies in new emerging markets
• Consider Value Based Pricing: Principles and practice
• Learn about the latest regulations within pricing and reimbursement
• Network with key industry experts in the field
Key Speakers Include:
• Markus Jahn, Manager, Pricing, Novartis Pharma GmbH
• Elke Hunsche, Director, Head Health Economics & Pricing, Actelion Pharmaceuticals
• Isabel Henkel, Director Access & Reimbursement, Johnson & Johnson
• Henderson Azevedo, Head of Pricing, Tender and Institutional Business , Novartis Group Emerging Markets
• Martina Garau, Economist, Office Of Health Economics
• Frank Thoss, Lawyer, Strategic Policy Affairs, German Association of Research-Based Pharmaceutical Companies
Plus, don't miss our two workshops:
Market Access in Emerging Markets: Overview of growth opportunities and key market access challenges in emerging markets
8.30am - 12.30pm, 2nd November 2011, Radisson Blu Hotel Basel, Basel, Switzerland
In association with IHS Global Insight
Cooperation with Payors as a Means for Attaining Reimbursement
1pm - 5pm, 2nd November 2011, Radisson Blu Hotel Basel, Basel
In association with Roman Rittweger Advisors in Healthcare
Visit www.smi-online.co.uk/2011europricing52.asp to reserve your place.
Alternatively, contact Ouasie Abdel-Razig on +44 (0) 20 7827 6734 or e-mail: oabdelrazig@smi-online.co.uk
Quote "EIN News" and save £100
Group discounts available
European Pharmaceutical Pricing & Reimbursement
31st October & 1st November 2011, Radisson Blu Hotel Basel, Basel, Switzerland
>>> New confirmed speaker: Gary Johnson, Managing Director, Inpharmation
who will be presenting on the following topic: New Realities and New Approaches in European Pricing Strategies
With only 3 weeks remaining, reserve your place today and be part of this exciting event where you will hear key industry speakers discussing the latest pricing and market access developments and challenges currently facing the pharmaceutical sector.
Attendees will be presented with pricing strategies and solutions to current issues in European pharmaceutical market access. Key industry experts will present updates on the VBP and the AMNOG, referring to real life case studies, strategies and success stories in health technology assessment mechanisms and pricing and reimbursement strategies. This year's event will act as the perfect forum for thought provoking discussions and networking with our diverse speaker line up, each offering a different industry perspective.
Key Topics Include:
EU policy challenges in access to medicines in Europe: the value of collaboration in HTA and managed entry schemes
• Assessment and Appraisal: is there a scope for European collaboration in HTA to prove clinical value to governments and payers?
• How the new challenges of "valuable innovation" can be addressed in order to meet priorities in healthcare?
• Will Managed Entry Schemes provide a refined tool to address uncertainties in patient's access?
• Can stakeholders contribute effectively to the setting of shared rules?
Andrea Rappagliosi, Vice President European Government Affairs & Head of Brussels Office, GSK
Benefits of Attending:
• Understand the facts and consequences of Germany's AMNOG
• Discuss EU policy challenges in access to medicines in Europe
• Analyse Market access strategies in new emerging markets
• Consider Value Based Pricing: Principles and practice
• Learn about the latest regulations within pricing and reimbursement
• Network with key industry experts in the field
Key Speakers Include:
• Markus Jahn, Manager, Pricing, Novartis Pharma GmbH
• Elke Hunsche, Director, Head Health Economics & Pricing, Actelion Pharmaceuticals
• Isabel Henkel, Director Access & Reimbursement, Johnson & Johnson
• Henderson Azevedo, Head of Pricing, Tender and Institutional Business , Novartis Group Emerging Markets
• Martina Garau, Economist, Office Of Health Economics
• Frank Thoss, Lawyer, Strategic Policy Affairs, German Association of Research-Based Pharmaceutical Companies
Plus, don't miss our two workshops:
Market Access in Emerging Markets: Overview of growth opportunities and key market access challenges in emerging markets
8.30am - 12.30pm, 2nd November 2011, Radisson Blu Hotel Basel, Basel, Switzerland
In association with IHS Global Insight
Cooperation with Payors as a Means for Attaining Reimbursement
1pm - 5pm, 2nd November 2011, Radisson Blu Hotel Basel, Basel
In association with Roman Rittweger Advisors in Healthcare
Visit www.smi-online.co.uk/2011europricing52.asp to reserve your place.
Alternatively, contact Ouasie Abdel-Razig on +44 (0) 20 7827 6734 or e-mail: oabdelrazig@smi-online.co.uk
Quote "EIN News" and save £100
Group discounts available
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.